Olfactory receptors (ORs) are a large family of G-protein-coupled receptors (GPCRs) that play a critical role in the sense of smell. These receptors are activated by odorant molecules, leading to a cascade of intracellular events that convert chemical signals into electrical signals perceived by the brain. The inhibition of ORs, and in this context, Olfr1029, involves targeting the signaling pathways associated with these receptors. The primary pathway of OR signaling involves the binding of an odorant to the receptor, leading to the activation of the G protein (Golf in olfactory neurons), which in turn activates adenylate cyclase. This activation results in the production of cyclic AMP (cAMP), a second messenger that opens cyclic nucleotide-gated ion channels, leading to cell depolarization and signal transmission. Chemicals like Forskolin and IBMX act by modulating the levels of cAMP, thereby indirectly influencing OR activity. Forskolin increases cAMP by directly stimulating adenylate cyclase, while IBMX inhibits phosphodiesterases, preventing cAMP breakdown.
Another aspect of OR signaling involves calcium dynamics and the activation of various kinases. BAPTA, a calcium chelator, can influence calcium-mediated processes in olfactory signal transduction. Kinase inhibitors like KN-93, PD98059, U0126, LY294002, Wortmannin, PP2, Genistein, and Gö6976 target different kinases that play roles in downstream signaling processes. These kinases are involved in pathways such as the MAPK/ERK pathway, PI3 kinase pathway, and others, all of which are crucial in the modulation of OR responses. NF449 is a selective inhibitor of the Gs alpha subunit, directly targeting the G protein involved in OR signaling. By inhibiting this subunit, NF449 can reduce the overall activity of the receptor. In summary, while direct inhibitors for Olfr1029 are not well-established, these chemicals provide potential means to modulate its activity indirectly by targeting key elements in the olfactory signaling pathways. This approach can be valuable for exploring the functional aspects of Olfr1029 and related olfactory receptors.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, thereby increasing cAMP levels which can modulate olfactory signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which can elevate cAMP, indirectly affecting olfactory receptor signaling. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $67.00 $262.00 | 10 | |
BAPTA is a calcium chelator, potentially affecting calcium-mediated processes in olfactory signal transduction. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II, which may be involved in olfactory transduction. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an inhibitor of MEK, which could indirectly influence olfactory receptor pathways via the MAPK/ERK pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is another MEK inhibitor, potentially affecting olfactory receptor signaling through the MAPK/ERK pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3 kinase inhibitor, which may indirectly impact olfactory receptor pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is also a PI3 kinase inhibitor, potentially affecting signaling pathways related to olfactory receptors. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is an Src family kinase inhibitor, which could have an indirect effect on olfactory receptor signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, which may indirectly affect olfactory receptor function. |